BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia S, Guo P, Lu J, Huang X, Deng L, Jin Y, Zhao L, Fan X. Curcumol Ameliorates Lung Inflammation and Airway Remodeling via Inhibiting the Abnormal Activation of the Wnt/β-Catenin Pathway in Chronic Asthmatic Mice. Drug Des Devel Ther 2021;15:2641-51. [PMID: 34188444 DOI: 10.2147/DDDT.S292642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Zhou Y, Wang Q, Chen J, Chen H, Xie H, Li L, Wang K. Conciliatory Anti-Allergic Decoction Attenuates Pyroptosis in RSV-Infected Asthmatic Mice and Lipopolysaccharide (LPS)-Induced 16HBE Cells by Inhibiting TLR3/NLRP3/NF-κB/IRF3 Signaling Pathway. Journal of Immunology Research 2022;2022:1-16. [DOI: 10.1155/2022/1800401] [Reference Citation Analysis]
2 Zhou B, Liu H, Jia X. The Role and Mechanisms of Traditional Chinese Medicine for Airway Inflammation and Remodeling in Asthma: Overview and Progress. Front Pharmacol 2022;13:917256. [DOI: 10.3389/fphar.2022.917256] [Reference Citation Analysis]
3 Yang F, Kong J, Zong Y, Li Z, Lyu M, Li W, Li W, Zhu H, Chen S, Zhao X, Wang J. Autophagy-Related Genes Are Involved in the Progression and Prognosis of Asthma and Regulate the Immune Microenvironment. Front Immunol 2022;13:897835. [PMID: 35619697 DOI: 10.3389/fimmu.2022.897835] [Reference Citation Analysis]
4 Yang L, Xiong H, Li X, Li Y, Zhou H, Lin X, Chan TF, Li R, Lai KP, Chen X. Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19. Front Nutr 2022;9:870370. [DOI: 10.3389/fnut.2022.870370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sun R, Xu G, Gao D, Ding Q, Shi Y. To Predict Anti-Inflammatory and Immunomodulatory Targets of Guizhi Decoction in Treating Asthma Based on Network Pharmacology, Molecular Docking, and Experimental Validation. Evid Based Complement Alternat Med 2021;2021:9033842. [PMID: 34966437 DOI: 10.1155/2021/9033842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]